Bachem
  • Products & Services
    • CMC Development
      • Peptide NCES
      • Oligonucleotide NCEs
    • Commercial API
      • Commercial NCEs
      • Commercial Generics
    • Research & Specialties
      • Catalog Peptides
      • Custom Peptide Synthesis
      • Amino Acid Derivatives
      • Diagnostics
      • Cosmetic Peptides
    • Services & Capabilities
      • Project Management
      • Quality & Regulatory
      • Analytical capabilities
      • GMP Production
      • Research Grade Production
      • Supply & vertical integration
  • About Bachem
    • Company overview
      • Our Purpose
      • Our vision & strategy
      • Our Leadership
      • Our History
      • Our Locations
    • Innovation
      • Innovation matters
      • Innovation collaborations
    • Sustainability
      • People & culture
      • Safeguarding the environment
      • Acting ethically
    • Investors & Media
      • Reports & Presentations
      • Financial events
      • Media Library
      • Press archive
  • News & Events
    • News
    • Events
  • Careers
  • Contact
Select Page

Bachem receives Abbott’s supplier excellence award.

June 30, 2010

Abbott presented its Supplier Excellence Award to Bachem Americas because of outstanding performance and continuous improvement in supplying materials, equipment and services.
Download

← Stephan Schindler to become new CFO of Bachem Group Difficult start to first half-year of 2010 for the Bachem Group →

The weight loss drug Liraglutide

Interview with Amy Zhang, Head of Supply Chain at Luye Pharma

What are oligonucleotides?

Somatostatin Analogues Provide Invaluable Therapeutic Options

What are somatostatin and somatostatin analogues?

Bachem innovating through virtual events

Meet Bachem: Pascal Hess, Group Leader Generics – Portfolio

A world market leader from the Basel region – Bachem celebrates 50 years of company history

What are Amino Acids?

Bachem recognized as a winner at the Swiss Biotech Success Stories Awards 2021

What is GMP?

Will Targeting Alpha-Synuclein Lead to Treatments for Parkinson’s Disease?

Meet Bachem: Swetlana Meinhardt, Category Manager

Peptides unlock doors to understand Parkinson’s disease

Interview with Robert Yu, CEO of Yuyu Pharma

What are peptides?

Bachem celebrates the hire of its 1000th employee at the Bubendorf site

GalNAc: Delivering Promise of Oligonucleotides

Bachem appoints new Head of Group Communications

Meet Bachem: Johannes Kremser, Group Leader R&D

Knowledge Center
General Conditions
Legal Statement
Privacy Policy
Imprint
Contact

  •  

  •  

  •  

  •  

  •